Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
11,503,641
-
Share change
-
-4,642,509
-
Total reported value
-
$357,839,259
-
Price per share
-
$31.21
-
Number of holders
-
90
-
Value change
-
-$145,370,830
-
Number of buys
-
36
-
Number of sells
-
22
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2025
As of 31 Dec 2025,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,503,641 shares.
The largest 10 holders included
Assenagon Asset Management S.A., Analyst IMS Investment Management Services Ltd., Allspring Global Investments Holdings, LLC, Y.D. More Investments Ltd, Union Bancaire Privee, UBP SA, BOURGEON CAPITAL MANAGEMENT LLC, Hennion & Walsh Asset Management, Inc., Retirement Systems of Alabama, SG Americas Securities, LLC, and DAVENPORT & Co LLC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.